Increased Risk of Second Malignancies In Young Patients with Mycosis Fungoides Diagnosed Before 30 Years of Age: A Population-Based Study
Weiyun Z. Ai(City College of San Francisco), Ellen T. Chang(Exponent (United States)), Kari Fish(Cancer Prevention Institute of California), Pincus Laura(University of California, San Francisco), Theresa H.M. Keegan(UC Davis Comprehensive Cancer Center), Youn H. Kim(Stanford University), Christopher W. M. Soon(University of California, San Francisco)
Cited by 0
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
|Journal of Clinical Oncology|2010|487